PL1 - Lyophilisate and solvent for solution for injection, sotatercept
A011-14
Phase 3 small_molecule active
Quick answer
PL1 - Lyophilisate and solvent for solution for injection, sotatercept for Pulmonary Arterial Hypertension (PAH) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Pulmonary Arterial Hypertension (PAH)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active